Term ends Jun 11, 2035 · Low confidence
20-year base term ends Jun 11, 2035
Reissue of US 9,469,613, which was surrendered when this reissue was granted; its term and maintenance fees continue here.
Held by GlaxoSmithKline LLC
Filed Oct 18, 2018 as application 16/164,681 · Granted Oct 27, 2020
Base term, 20 years from filing
Today
2015
2035
Clock starts
Jun 11, 2015
Jun 11, 2015
Term ends
Jun 11, 2035
Jun 11, 2035
Granted
Oct 27, 2020
Oct 27, 2020
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from the original patent's grant (Oct 18, 2016). This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 11, 2015, when application 14/736,690, the earliest non-provisional in its chain, was filed (this one was filed Oct 18, 2018) | Jun 11, 2035 | High confidence |
| Continuity chain | A reissue: its term follows the original patent's, with the original's term adjustment | follows the original patent | Medium confidence |
| Patent term adjustment | No term adjustment record on a grant after 2005, so none is added | no change | Medium confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 11, 2035 | Low confidence |
This family
| US 9,469,613 | Surrendered on reissue Oct 2020 | Oct 2020 |
| US 9,809,559 | In force no later than Jun 2035 | no later than Jun 2035 |
| US RE48,285 | this patent Jun 2035 | Jun 2035 |
| US RE49,445 | In force Jun 2035 | Jun 2035 |
| US RE50,497 | In force no later than Jun 2035 | no later than Jun 2035 |
| Application 19/245,507 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 15, 2018 Reel 47517, frame 920 | Gilead Sciences, Inc. | Sierra Oncology, Inc. | Assignment of Assignor's Interest |
| Jun 11, 2020 Reel 52910, frame 531 | Brown, Brandon H.; Carra, Ernest A.; Hemenway, Jeffrey N.; Morrison, Henry; Reynolds, Troy; Shi, Bing; Stefanidis, Dimitrios; Wang, Fang; Warr, Matthew Robert; Whitney, James Andrew; Xin, Yan | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| May 26, 2023 Reel 63790, frame 568 | Sierra Oncology, Inc. | Sierra Oncology LLC | Change of Name |
| Jun 7, 2023 Reel 63879, frame 821 | Sierra Oncology LLC | GlaxoSmithKline LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2035
Term ends Jun 11, 2035. Maintenance fees still fall due before then
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.